Clinical phase I and pharmacology study of gemcitabine (2', 2'-difluorodeoxycytidine) administered in a two-weekly schedule.

Source:http://linkedlifedata.com/resource/pubmed/id/17434832

Download in:

View as

General Info

PMID
17434832